Polish Children's Hospital Splits Blood-Derived Medicine Contracts Among Four Pharmaceutical Suppliers
15 Jul 2026
Standfirst: A public children's hospital in Bydgoszcz has awarded four contracts for the year long supply of immunoglobulins and albumin to Takeda Pharma, URTICA, NOBIPHARM and CSL Behring. The procurement highlights how hospitals divide critical blood derived medicines into separate lots to protect supply continuity while allowing specialist pharmaceutical suppliers to compete for individual product categories. For children living with immune disorders, neurological diseases and other serious medical conditions, access to blood derived medicines is not simply a matter of hospital inventory. Treatment can depend on a reliable supply of specialised products that are difficult to manufacture, tightly regulated and vulnerable to changes in global plasma availability. That makes a new procurement decision in Bydgoszcz more significant than its four supply contracts might initially suggest. The Wojewódzki Szpital Dziecięcy im. J. Brudzińskiego, a specialist children's hospital in northern Poland, has selected four pharmaceutical suppliers to provide different categories of immunoglobulins and albumin over a 12 month period. Rather than relying on a single company, the hospital divided the procurement into four lots and awarded each product category separately. Takeda Pharma secured the largest value lot, while URTICA, NOBIPHARM and CSL Behring won contracts covering other concentrations of immunoglobulins and albumin. Why This Contract Matters Immunoglobulins are medicines produced from donated human plasma. They contain antibodies that help the immune system fight infection and are used to treat a range of immune deficiencies, autoimmune disorders and neurological conditions. For some patients, regular treatment is essential to prevent serious illness or control disease progression. Albumin is another plasma derived product. It is used in clinical situations where patients need support in maintaining blood volume and fluid balance, including some cases involving major surgery, severe illness or critical care. Unlike many conventional medicines, plasma derived therapies depend on a complex international supply chain that begins with human plasma collection and continues through lengthy manufacturing, purification, safety testing and regulatory processes. Hospitals therefore need procurement arrangements that provide both competitive pricing and dependable access to treatment. For the Bydgoszcz children's hospital, dividing the requirement into four lots allowed suppliers to compete for the specific product categories they were equipped to deliver. The result is a diversified supplier base rather than dependence on one company for the entire requirement. Contract Timeline Previous Contract Notice: TED Notice 282110-2026 Contract Signed for Lot 1: 19 June 2026 Contract Signed for Lot 2: 23 June 2026 Contracts Signed for Lots 3 and 4: 19 June 2026 Supply Period: 1 July 2026 to 30 June 2027 Contract Award Notice Published: 15 July 2026 Contract Overview The procurement covers successive deliveries of blood derived medicinal products to the Wojewódzki Szpital Dziecięcy im. J. Brudzińskiego in Bydgoszcz. Supplies will be delivered according to the hospital's requirements during the contract period rather than necessarily being provided in a single shipment. The requirement was divided into four lots: 10% immunoglobulins, two separate categories of 5% immunoglobulins and 20% albumin. All four lots resulted in contract awards. The hospital also retained an option to increase the quantity supplied under each contract by up to 10% of the value of the corresponding base order. This gives the buyer flexibility to respond to actual treatment demand without launching a new procurement procedure. Key Contract Details Contracting Authority Wojewódzki Szpital Dziecięcy im. J. Brudzińskiego w Bydgoszczy Country Poland Location Bydgoszcz, Kujawsko Pomorskie Contract Type Supplies Procurement Procedure Open procedure Number of Lots 4 Successful Suppliers Takeda Pharma Sp. z o.o.; URTICA Sp. z o.o.; NOBIPHARM Sp. z o.o.; CSL BEHRING Sp. z o.o. Contract Period 1 July 2026 to 30 June 2027 Award Criterion Price – 100% Main CPV Code 33651520 – Immunoglobulins Additional CPV Code 33621400 – Blood substitutes and perfusion solutions EU Procurement Directive Directive 2014/24/EU TED Notice ID 488806-2026 Lot by Lot Award Results Lot Product Category Winning Supplier Reported Tender Value Tenders Received Lot 1 10% Immunoglobulins Takeda Pharma Sp. z o.o. PLN 24,744,500 2 Lot 2 5% Immunoglobulins I URTICA Sp. z o.o. PLN 944,058.50 2 Lot 3 5% Immunoglobulins II NOBIPHARM Sp. z o.o. PLN 88,000 1 Lot 4 20% Albumin CSL BEHRING Sp. z o.o. PLN 16,280 5 Note: The values above are reproduced as reported in the TED award notice. Some reported tender values appear inconsistent with the separate admissible tender ranges stated in the notice and should therefore be interpreted with caution. Project Scope The contracts provide for successive deliveries of four categories of plasma derived medicines during the 12 month supply period. Lot 1: Supply of 10% immunoglobulin products. Lot 2: Supply of the first category of 5% immunoglobulin products. Lot 3: Supply of the second category of 5% immunoglobulin products. Lot 4: Supply of 20% albumin products. The 10% immunoglobulin products procured under Lot 1 may be used within Poland's National Health Fund reimbursement programme for the treatment of neurological diseases with immunoglobulins. This connects the procurement directly to the continuity of publicly funded specialist treatment. The contracts also include a purchasing option of up to 10% above the value of each base order. The hospital may use this option in full or in part according to actual demand, without requiring a separate contract amendment. About the Contracting Authority Wojewódzki Szpital Dziecięcy im. J. Brudzińskiego w Bydgoszczy is a public children's hospital serving Bydgoszcz and the wider Kujawsko Pomorskie region. As a specialist paediatric healthcare institution, it provides medical services to children requiring hospital treatment, diagnostics and specialist care. The hospital conducted the procurement as a body governed by public law under Poland's public procurement framework. By arranging scheduled deliveries across a full year, the hospital aims to maintain access to essential blood derived medicines while managing pharmaceutical inventory according to clinical demand. About the Organisations Involved Takeda Pharma Sp. z o.o. – Winner of Lot 1 Takeda Pharma Sp. z o.o. won the contract for 10% immunoglobulins, the largest product category in the procurement by reported award value. The company is the Polish operation of Takeda, an international biopharmaceutical group with activities across specialised medicines, including plasma derived therapies. Two tenders were received for the lot. Takeda's offer was ranked first under the procurement's price only evaluation model. The contract was concluded on 19 June 2026 and does not involve subcontracting. URTICA Sp. z o.o. – Winner of Lot 2 URTICA Sp. z o.o. secured the first lot covering 5% immunoglobulins. The Wrocław based company operates in pharmaceutical distribution and supplies medicines to healthcare institutions across Poland. The lot attracted two tenders, including one from a small or medium sized enterprise. URTICA's offer ranked first and the contract was concluded on 23 June 2026. No subcontracting was declared. NOBIPHARM Sp. z o.o. – Winner of Lot 3 NOBIPHARM Sp. z o.o. won the second category of 5% immunoglobulins. The Warsaw based pharmaceutical supplier was identified in the notice as a small enterprise. Only one tender was received for this lot, making NOBIPHARM the sole bidder. The contract was concluded on 19 June 2026, with no subcontracting planned. CSL BEHRING Sp. z o.o. – Winner of Lot 4 CSL BEHRING Sp. z o.o. secured the contract for 20% albumin. CSL Behring specialises in plasma derived and other therapies used in the treatment of rare and serious diseases. Lot 4 attracted five tenders, the highest level of competition among the four product categories. CSL Behring's offer was ranked first and the contract was concluded on 19 June 2026. The supplier did not declare any subcontracting. Krajowa Izba Odwoławcza – Procurement Review Body Krajowa Izba Odwoławcza, Poland's National Appeals Chamber, is the review authority for the procurement. It provides the formal mechanism through which suppliers may challenge procurement decisions where they believe public procurement rules have been breached. Procurement Analysis The hospital used an open procedure, allowing qualified suppliers to submit bids for one or more of the four lots. The procurement was not accelerated and all tenders were submitted electronically. Price carried a weighting of 100% across all four lots. This means the hospital selected the lowest priced admissible offer after confirming that the bidder met the required legal, technical and procurement conditions. The procurement also used Poland's so called reverse procedure. Under this approach, the contracting authority first evaluates and ranks the offers and then conducts detailed eligibility checks on the highest ranked supplier. The method can reduce administrative work because full qualification checks do not have to be completed for every bidder at the initial evaluation stage. Competition varied considerably by product category. The 20% albumin lot attracted five tenders, while the second 5% immunoglobulin lot received only one. This difference suggests that supplier availability and competitive intensity are not uniform across the plasma derived medicines market. Additional Procurement Facts Legal Basis: Directive 2014/24/EU Nature of Contract: Supplies Procedure: Open procedure Accelerated Procedure: No Award Criterion: Price – 100% Framework Agreement: No Dynamic Purchasing System: No Government Procurement Agreement: Covered EU Funding: No EU funding involved Contract Option: Up to 10% additional supply value for each lot Subcontracting: Not declared by any of the four successful suppliers Review Authority: Krajowa Izba Odwoławcza Market & Industry Perspective The market for plasma derived medicines operates under conditions that differ from those of conventional pharmaceutical manufacturing. Production depends on the availability of donated human plasma, while manufacturing and safety controls can take several months. This limits how quickly supply can respond when demand rises. The varying number of bids across the four lots offers a useful view of competition within individual product categories. Albumin attracted five offers, suggesting a broader competitive field, while one immunoglobulin lot received only a single bid. For public healthcare buyers, limited competition in specific formulations may increase the importance of early procurement planning and supplier engagement. Future procurement opportunities are likely to emerge as hospitals renew annual medicine supply contracts, adjust quantities to changing treatment demand and use optional purchasing provisions where consumption exceeds initial forecasts. Economic Significance The largest reported award went to Takeda Pharma for the supply of 10% immunoglobulins. This reflects the importance of concentrated immunoglobulin therapies within specialist treatment and Poland's publicly funded neurological treatment programmes. The economic significance of the procurement extends beyond the individual award values. Reliable access to these medicines can help hospitals maintain treatment schedules, reduce the operational risk associated with supply interruptions and provide greater predictability in pharmaceutical expenditure. The 10% option attached to every lot also creates controlled financial flexibility. Rather than committing immediately to maximum quantities, the hospital can increase purchases if clinical demand requires additional supply. Future Procurement Opportunities The contracts are scheduled to end on 30 June 2027, creating a potential future procurement cycle before the current supply period expires. Suppliers active in immunoglobulins, albumin and plasma derived therapies should monitor procurement activity from the Bydgoszcz children's hospital and other Polish healthcare institutions during the first half of 2027. Additional opportunities may arise earlier if treatment demand exceeds the hospital's original forecasts. However, the existing contracts allow the hospital to increase purchases by up to 10%, meaning some additional demand may be met through the current suppliers rather than through a new tender. Future competitions may also reflect changes in medicine availability, reimbursement programmes, clinical demand and pricing across the European plasma products market. Opportunities for Suppliers Manufacturers and authorised pharmaceutical distributors can use similar hospital procurements to build a pipeline of recurring public sector opportunities. The lot based structure allows suppliers to compete for individual product categories without needing to provide the hospital's entire portfolio of blood derived medicines. Companies seeking future opportunities should maintain the regulatory approvals, distribution capacity and product availability needed to support uninterrupted hospital supply. Monitoring annual contract expiry dates may also help suppliers identify upcoming tenders before formal notices are published. The participation of both large pharmaceutical companies and a small enterprise among the successful bidders shows that specialised suppliers can compete effectively when contracts are divided into focused product lots. What Businesses Should Watch Renewal procurement before the current contracts expire on 30 June 2027. Future immunoglobulin and albumin tenders from Polish hospitals and regional healthcare authorities. Changes in demand under Poland's publicly funded immunoglobulin treatment programmes. Whether hospitals increase contract quantities through purchasing options. Competition levels for specialised immunoglobulin concentrations where few suppliers submit bids. Changes in European plasma availability and their effect on medicine pricing and procurement strategy. PolandTenders.com Procurement Intelligence This award reflects a broader procurement strategy in which healthcare buyers divide specialised pharmaceutical requirements into product specific lots rather than placing the entire supply obligation with one company. The approach can widen participation, improve price competition and reduce dependence on a single supplier. The tender results also show that the blood derived medicines market cannot be treated as one uniform category. Competition ranged from one tender for Lot 3 to five tenders for Lot 4. For buyers, this means procurement strategy may need to be adapted to the supplier depth available for each medicine and concentration. For suppliers, the opportunity is not limited to major national medicine contracts. Annual hospital level procurements can provide recurring business, particularly for companies able to demonstrate reliable product availability and fulfil scheduled deliveries over extended periods. The use of a 10% purchasing option is also strategically important. It gives the hospital a buffer against changes in patient demand while allowing successful suppliers to capture additional orders during the contract period. Future tenders may increasingly use similar flexibility where medicine consumption is difficult to forecast precisely. Supplier Takeaways Track annual immunoglobulin and albumin supply contracts across Poland's public healthcare system. Monitor contract expiry dates well before renewal notices are published. Prepare for price led competitions where technical compliance is mandatory but price determines final ranking. Evaluate opportunities lot by lot, as competition differs significantly between product categories. Maintain sufficient inventory and distribution capacity to support successive hospital deliveries. Consider the additional commercial potential created by quantity options in awarded contracts. Key Takeaways A public children's hospital in Bydgoszcz awarded four contracts for immunoglobulins and albumin supplies. Takeda Pharma, URTICA, NOBIPHARM and CSL Behring each won one product lot. The contracts cover supplies from 1 July 2026 to 30 June 2027. The procurement was conducted through an open procedure under Directive 2014/24/EU. Price accounted for 100% of the award evaluation. Competition ranged from one tender for a 5% immunoglobulin lot to five tenders for the albumin lot. Each contract includes an option allowing the hospital to increase supply by up to 10% of the base order value. No EU funding, framework agreement or dynamic purchasing system was involved. Conclusion Behind every hospital medicine contract is a practical question: will the required treatment be available when a patient needs it? For a children's hospital managing specialised and potentially life sustaining therapies, supply continuity is as important as procurement price. By dividing its requirement among Takeda Pharma, URTICA, NOBIPHARM and CSL Behring, the Bydgoszcz hospital has created a multi supplier structure covering four categories of immunoglobulins and albumin. The awards also reveal a market with uneven competition, where some products attract several suppliers while others depend on a much narrower field. For pharmaceutical companies and distributors, the procurement points to a recurring opportunity in Poland's public healthcare market: specialised medicine contracts that reward regulatory readiness, reliable distribution and the ability to compete within precisely defined product categories. Frequently Asked Questions What medicines are covered by the contracts? The procurement covers 10% immunoglobulins, two categories of 5% immunoglobulins and 20% albumin. Which companies won the contracts? Takeda Pharma Sp. z o.o. won Lot 1, URTICA Sp. z o.o. won Lot 2, NOBIPHARM Sp. z o.o. won Lot 3 and CSL BEHRING Sp. z o.o. won Lot 4. What are immunoglobulins? Immunoglobulins are antibody based medicines produced from donated human plasma. They are used to treat immune deficiencies, autoimmune conditions and certain neurological diseases. What is albumin used for? Albumin is a plasma derived protein used in clinical care to help maintain blood volume and fluid balance in certain serious medical conditions. How long will the contracts run? The supply period runs from 1 July 2026 to 30 June 2027. How were the winning suppliers selected? The contracts were awarded through an open procedure. Price represented 100% of the award evaluation after suppliers met the procurement's eligibility and technical requirements. How many tenders were received? Lots 1 and 2 each received two tenders, Lot 3 received one tender and Lot 4 received five tenders. Can the hospital purchase additional quantities? Yes. Each contract includes an option allowing the hospital to increase purchases by up to 10% of the value of the corresponding base order. Was the procurement financed by the European Union? No. The TED notice states that the procurement is not financed with EU funds. Source: Tenders Electronic Daily (TED), Contract Award Notice 488806-2026, published on 15 July 2026.
View Details
Poland’s Social Security Institution Awards PLN 10.09 Million Data Protection Software Contract to Engave
14 Jul 2026
Poland’s national social security institution is strengthening the technology used to protect and recover critical public-sector data. Zakład Ubezpieczeń Społecznych has awarded a PLN 10.09 million contract to Warsaw-based Engave S.A. for Veeam Data Platform Advanced software, or an equivalent solution, together with long-term technical and manufacturer support. Introduction Every pension payment, social insurance contribution and public benefit depends on digital systems that must remain available even when technology fails, data is damaged or cyber incidents disrupt normal operations. For an institution operating at national scale, data protection is not simply an IT maintenance issue. It is part of the infrastructure that keeps essential public services functioning and allows critical information to be recovered when systems face technical failure, human error or cyber disruption. Poland’s Zakład Ubezpieczeń Społecznych, commonly known as ZUS, has now awarded a major software contract to Engave S.A. for the supply of Veeam Data Platform Advanced licences, or an equivalent platform, together with technical support. The PLN 10,090,517.92 contract will run for 48 months and includes an option allowing ZUS to purchase an additional 1,200 perpetual software licences. The procurement attracted three electronic tenders, all submitted by small or medium-sized businesses. Why This Contract Matters ZUS administers a large part of Poland’s social security system. Its digital infrastructure supports processes connected with pensions, insurance contributions, benefits and services used by employers, employees and citizens across the country. That scale makes the availability and recoverability of data operationally important. A disruption affecting critical systems can create consequences beyond the IT department, potentially affecting public administration, institutional workflows and access to essential services. Veeam Data Platform Advanced is designed around data protection, backup management, recovery and operational resilience. By allowing equivalent software, the procurement remained open to alternative solutions capable of meeting the authority’s technical requirements rather than restricting competition solely to one named product. The four-year support period is also significant. Enterprise software procurement does not end when licence keys are delivered. Public institutions require technical assistance, updates and access to specialist support throughout the operating life of the platform. Contract Timeline Previous TED Notice: 291175-2026 Winner Selected: 24 June 2026 Contract Concluded: 10 July 2026 Notice Dispatched: 13 July 2026 TED Publication Date: 14 July 2026 Contract Duration: 48 months Contract Overview The procurement covers the purchase of Veeam Data Platform Advanced software or an equivalent platform, together with support services. The main contract is classified as a software supply, while technical and support services form an additional part of the requirement. The contract was awarded through an open procedure under Article 132 of Poland’s Public Procurement Law and Directive 2014/24/EU. The procedure was not accelerated. Engave S.A. submitted the winning tender with a value of PLN 10,090,517.92. The company was ranked first after the authority evaluated bids entirely on price. The contract does not establish a framework agreement and does not use a Dynamic Purchasing System. Engave will deliver the requirement through a direct four-year contract. Key Contract Details Contract Information Details Project Purchase of Veeam Data Platform Advanced software or equivalent, together with support Contracting Authority Zakład Ubezpieczeń Społecznych Winning Company Engave S.A. Country Poland Place of Performance Across Poland Sector Enterprise software, data protection and IT support Main Nature of Contract Supplies Additional Nature Services Procurement Procedure Open procedure Winning Contract Value PLN 10,090,517.92 Contract Duration 48 months Award Criterion Price - 100% Electronic Tenders Received 3 SME Tenders Received 3 Winner Selected 24 June 2026 Contract Concluded 10 July 2026 Main CPV Code 48000000 - Software package and information systems Additional CPV Codes 72268000 - Software supply services; 72611000 - Technical computer support services EU Procurement Directive Directive 2014/24/EU Framework Agreement No Dynamic Purchasing System No EU Funding No EU funding involved GPA Coverage Yes Subcontracting No TED Notice ID 486055-2026 TED Publication Date 14 July 2026 Project Scope The contract centres on the supply of Veeam Data Platform Advanced software or an equivalent solution. Platforms in this category help organisations manage data protection, backup, recovery and resilience across complex digital environments. The detailed technical specifications are contained in the procurement documents and were not reproduced in full in the contract award notice. However, the procurement clearly combines software licensing with ongoing technical support. The contract also includes an option that could expand the deployment. ZUS may make a one-time additional purchase of 1,200 perpetual licences for the same software supplied under the main order. A perpetual licence generally provides a continuing right to use a specified version of the software rather than requiring the institution to renew access through a recurring subscription. Support and software maintenance may still operate for a defined period under separate contractual terms. If ZUS exercises the option, Engave will also provide service support and ensure access to manufacturer support on a 24-hour, seven-day-a-week, 365-day basis for the additional licences. This support will continue from the delivery of the licence keys until the end of the support period established under the main contract. ZUS may exercise the option within six months after signing the acceptance protocol for the licences delivered under the basic order. About the Contracting Authority Zakład Ubezpieczeń Społecznych Zakład Ubezpieczeń Społecznych, widely known as ZUS, is Poland’s national social insurance institution. It administers major elements of the country’s social security system and provides services connected with insurance contributions, pensions and public benefits. ZUS is classified as a body governed by public law and carries out general public-service activities. Its Public Procurement Department managed this procurement and is responsible for providing additional information concerning the procedure. The institution’s national responsibilities make the reliability of its digital environment strategically important. Software supporting data protection and recovery contributes to the continuity of systems used for large-scale public administration. About the Organisations Involved Engave S.A. Engave S.A. is the successful supplier for the software and support contract. The Warsaw-based technology company was ranked first with a tender valued at PLN 10,090,517.92. The TED notice classifies Engave as a small economic operator. Its success in a national public-sector technology procurement demonstrates that major government IT contracts are not limited to the largest multinational suppliers. Engave will supply the required software platform and associated support services. The contract does not involve subcontracting, meaning the winning company has not declared that any part of the awarded requirement will be transferred to subcontractors. The award notice identifies Engave as the only successful tenderer. No consortium members, joint-venture partners or additional successful suppliers are listed. Krajowa Izba Odwoławcza Krajowa Izba Odwoławcza, Poland’s National Appeals Chamber, is the review organisation identified for the procurement. It also provides additional information concerning review procedures. The chamber is responsible for hearing challenges relating to public procurement procedures. Its role is independent of contract delivery and provides a formal review mechanism for economic operators seeking to challenge procurement decisions. Procurement Analysis ZUS used an open procedure, allowing qualified suppliers to submit offers under the conditions established in the procurement documents. The process was conducted under Article 132 of Poland’s Public Procurement Law and Directive 2014/24/EU. Three electronic tenders were received. All three came from micro, small or medium-sized businesses registered in Poland. No bids were submitted by suppliers based in other European Economic Area countries or outside the EEA. The award was decided entirely on price. The lowest-priced compliant offer was therefore selected as the most economically advantageous tender. A 100% price criterion can be appropriate where technical requirements are defined in sufficient detail and competing products are expected to meet the same minimum performance standards. In this case, the authority specified Veeam Data Platform Advanced or an equivalent solution, meaning suppliers offering alternatives would still need to demonstrate compliance with the required technical conditions. The procurement does not use a framework agreement or Dynamic Purchasing System. This creates a direct contractual relationship between ZUS and Engave for the full 48-month period. Additional Procurement Facts The procurement was conducted through an open procedure. The procedure was not accelerated. The contract is governed by Directive 2014/24/EU. The main nature of the procurement is supplies. Technical computer support forms an additional service component. The main CPV code is 48000000 for software packages and information systems. Additional CPV classifications cover software supply and technical computer support services. Price was the only award criterion and carried a weighting of 100%. Three tenders were submitted electronically. All three tenders came from micro, small or medium-sized businesses. No tenders were received from companies registered outside Poland. The winning tender was ranked first. The successful offer was not submitted as a variant. No subcontracting was declared. No framework agreement was established. No Dynamic Purchasing System was used. The procurement is covered by the Government Procurement Agreement. The project is not financed through European Union funds. Market & Industry Perspective Public institutions are placing greater importance on the ability to recover data and restore digital services after system failures, cyber incidents and other operational disruptions. As government services become more dependent on large digital platforms, backup and recovery technology is increasingly part of core public infrastructure. The ZUS award reflects demand for platforms that combine software licensing with long-term technical support. Government buyers are not only purchasing technology; they are also seeking operational continuity, access to specialist assistance and support arrangements that remain available throughout the contract period. The procurement also demonstrates that smaller domestic technology companies can compete successfully for major public-sector software contracts. All three bids came from SMEs, suggesting an active Polish supplier market capable of delivering enterprise technology solutions to large public institutions. The option for 1,200 additional perpetual licences could create further demand within the existing contract if ZUS decides to expand deployment. Future procurement may also emerge around system integration, infrastructure modernisation, cyber resilience and long-term support as the institution’s technology environment evolves. Economic Significance The PLN 10.09 million award represents a substantial investment in software licensing and technical support rather than physical infrastructure. Its economic value lies in supporting the availability and recoverability of digital systems used by one of Poland’s most important public institutions. Reliable data protection can reduce the operational and financial impact of system failures by supporting faster recovery and limiting disruption. For a national social insurance institution, the value of resilience may extend beyond the purchase price because prolonged technology outages can affect large numbers of users and administrative processes. The award is also notable for SME participation. Engave is classified as a small economic operator, while all three tenders were submitted by small or medium-sized businesses. This indicates that high-value public-sector technology procurement can create meaningful opportunities for specialised domestic suppliers. Future Procurement Opportunities The most immediate potential expansion is the option for an additional 1,200 perpetual software licences. ZUS may exercise this option once within six months after accepting the licences delivered under the main order. If the option is used, the additional licences must be the same as the software supplied under the basic contract. They will also receive contractor support and continuous manufacturer support until the main support period ends. Beyond the current contract, future opportunities may emerge as ZUS expands its data infrastructure, modernises digital services or introduces additional requirements relating to backup, recovery, cyber resilience and technology support. The four-year contract period may also create a future renewal opportunity when the current support arrangements approach expiry. Suppliers should monitor ZUS procurement plans well before the end of the contract because major enterprise software requirements often involve technical evaluation and budget preparation long before a new tender is published. Opportunities for Suppliers No subcontracting has been declared under the awarded contract, limiting immediate opportunities to participate through the winning supplier. However, the procurement provides useful market intelligence for technology companies seeking future public-sector business in Poland. Potential areas for future demand include: Enterprise backup and data-recovery platforms. Cyber-resilience and disaster-recovery solutions. Software licensing and licence-management services. Technical computer support. Cloud and hybrid-infrastructure protection. Data-centre modernisation. Infrastructure monitoring and management tools. System integration and migration services. Security testing and operational resilience assessments. Manufacturer-backed support services. Public-sector IT consulting and implementation. Training and technical knowledge-transfer services. Suppliers offering equivalent products should prepare clear technical evidence showing that their platforms meet or exceed the functionality, compatibility and support requirements associated with named enterprise software products. What Businesses Should Watch Whether ZUS exercises the option for an additional 1,200 perpetual licences. The timing of licence acceptance, which begins the six-month option period. Future ZUS procurement involving data protection and cyber resilience. Additional requirements for backup, recovery and infrastructure management. Long-term support and renewal opportunities approaching the end of the 48-month contract. Public-sector demand for equivalent alternatives to established enterprise software products. Opportunities for SMEs in large Polish government technology procurements. Similar software and data-resilience tenders from other Polish public institutions. PolandTenders.com Procurement Intelligence This award reflects a broader change in government technology procurement. Data protection is moving from a back-office IT function to an operational-resilience priority because public services increasingly depend on the continuous availability of digital information. The contract also shows how public buyers can reference an established software platform while preserving competition through an “or equivalent” requirement. For alternative technology providers, however, eligibility alone is not enough. Suppliers must demonstrate technical equivalence in a form that procurement evaluators can verify. The use of price as the sole award criterion suggests that ZUS sought to standardise technical quality through mandatory specifications before comparing commercial offers. Once minimum requirements were met, the lowest price determined the winner. For suppliers, this places greater importance on procurement preparation. Companies must understand licensing structures, manufacturer-support obligations and compatibility requirements before pricing their offers because there may be little opportunity to differentiate through qualitative scoring. The strong participation of Polish SMEs is another important signal. All three bids came from smaller businesses, and a small Warsaw-based technology company secured a contract worth more than PLN 10 million. Specialist capability and competitive pricing can therefore provide a route into large public-sector technology contracts even without the scale of a multinational IT group. The next opportunity may not require a new tender immediately. ZUS already has the contractual ability to add 1,200 licences. Suppliers monitoring the market should therefore track both new procurement notices and the use of options within existing government technology contracts. Supplier Takeaways Monitor public-sector demand for backup, recovery and cyber-resilience technology. Prepare detailed equivalence documentation when competing against a named software platform. Build pricing models that account for long-term technical and manufacturer support. Review optional quantities because they may significantly expand the commercial value of a contract. Track ZUS technology procurement before the current 48-month support period expires. Maintain strong manufacturer relationships where continuous vendor support is mandatory. Prepare for price-led competitions when technical requirements are established as minimum conditions. SMEs should not assume that major national public-sector IT contracts are beyond their reach. Key Takeaways ZUS awarded a PLN 10,090,517.92 software and technical-support contract to Engave S.A. The procurement covers Veeam Data Platform Advanced or an equivalent solution. The contract will run for 48 months. ZUS may purchase an additional 1,200 perpetual licences through a one-time option. The optional licences will receive contractor support and continuous manufacturer support. Three electronic tenders were received, all from SMEs. Engave is classified as a small economic operator. The contract was awarded entirely on price. No subcontracting has been declared. The project does not involve EU funding but is covered by the Government Procurement Agreement. Conclusion Poland’s social security system depends on digital infrastructure that must remain available when technology fails or operational disruption occurs. The award to Engave therefore represents more than a software purchase. It is an investment in the protection and recoverability of data supporting essential public services. The PLN 10.09 million contract combines enterprise software with four years of technical support and gives ZUS the flexibility to expand the deployment through an additional 1,200 perpetual licences. The procurement also sends a wider market signal. Three SMEs competed, and a small Polish technology company secured a major national public-sector contract. For specialist suppliers, the award demonstrates that enterprise capability, technical compliance and competitive pricing can create access to significant government technology opportunities. Frequently Asked Questions What software is ZUS purchasing? ZUS is purchasing Veeam Data Platform Advanced software or an equivalent solution, together with technical support. Who won the ZUS software contract? Engave S.A., a Warsaw-based technology company classified as a small economic operator, won the contract. What is the value of the contract? The awarded contract is valued at PLN 10,090,517.92. How long will the contract run? The estimated contract duration is 48 months. What does Veeam Data Platform Advanced do? It is an enterprise data-protection platform designed to support functions such as backup management, data recovery and operational resilience. The detailed technical requirements for this procurement are contained in the tender documentation. Can ZUS purchase additional software licences? Yes. ZUS has a one-time option to purchase an additional 1,200 perpetual licences for the same software supplied under the main contract. How long does ZUS have to exercise the option? ZUS may exercise the option within six months after signing the acceptance protocol for the licences delivered under the basic order. How many tenders were received? Three electronic tenders were received, and all were submitted by micro, small or medium-sized businesses. How was the winner selected? Price was the only award criterion and carried a weighting of 100%. The lowest-priced compliant offer was selected. Does the contract involve subcontracting? No. The winning tender states that subcontracting will not be used. Is the project financed through European Union funds? No. The contract award notice states that the procurement is not financed through EU funds. Is the procurement covered by the Government Procurement Agreement? Yes. The procurement is covered by the Government Procurement Agreement. Source: Tenders Electronic Daily (TED), Contract Award Notice 486055-2026, published on 14 July 2026.
View Details
Poland Secures Five Year Power Line Supply Framework Worth PLN 362 Million
13 Jul 2026
Poland's transmission system operator has selected NPA Skawina and Fabryka Przewodów Energetycznych for a five year framework covering the supply of phase conductors used in the country's high voltage electricity network. With a maximum value of PLN 362.08 million, the agreement gives Polskie Sieci Elektroenergetyczne a long term procurement route for critical grid components while preserving competition between the two approved suppliers. Introduction Electricity grids are often judged by the infrastructure people can see: transmission towers crossing the landscape, substations at the edge of cities and new power connections serving homes, factories and renewable energy projects. Yet the reliability of those networks also depends on a less visible component, the conductors suspended between transmission towers that carry electricity across long distances. Poland has now secured a five year supply framework for these critical power line components. Polskie Sieci Elektroenergetyczne S.A. (PSE), the country's transmission system operator, has selected NPA Skawina Sp. z o.o. and Fabryka Przewodów Energetycznych S.A. as framework suppliers for phase conductors. The framework has a maximum value of PLN 362.08 million and is designed to support future orders through renewed competition between the selected companies. The procurement is not a contract for one transmission line or a single construction project. It is a long term supply mechanism intended to give PSE access to essential grid materials as requirements emerge across its electricity network. Why This Contract Matters Phase conductors are the cables that carry electrical current along overhead transmission lines. They form one of the most important physical links between power generation facilities, substations, industrial centres and regional electricity networks. Without a reliable supply of conductors, transmission projects can face delays even when towers, substations and construction teams are ready. Long manufacturing cycles, technical certification requirements and changing raw material prices can make advance procurement planning particularly important. The five year framework gives PSE a structured route for purchasing conductors without launching a completely new open tender every time demand arises. At the same time, the framework does not hand all future orders automatically to one company. PSE intends to reopen competition between the selected suppliers when awarding individual call off contracts, allowing price and supply conditions to be tested as requirements develop. The agreement therefore combines long term supply security with continuing competition, a procurement model that can be valuable when infrastructure demand is substantial but exact delivery volumes and schedules may change over time. Contract Timeline Previous Contract Notice: TED Notice 31645-2026 Winner Selection Date: 30 April 2026 Framework Contracts Signed: 7 July 2026 Contract Award Notice Published: 13 July 2026 Framework Duration: Five years from the date of signing, subject to the maximum framework value being reached earlier Maximum Renewals: None Contract Overview The procurement establishes a framework agreement for the future supply of phase conductors required by Polskie Sieci Elektroenergetyczne. Phase conductors are the electrically active cables carried by overhead transmission towers. Their purpose is to transport electricity across the high voltage network while meeting strict requirements relating to electrical capacity, mechanical strength, durability and operating conditions. The framework has a maximum value of PLN 362,076,000 and will remain in force for five years from signing or until the combined value of orders awarded under it reaches the contractual ceiling, whichever occurs first. PSE selected two suppliers: NPA Skawina Sp. z o.o. and Fabryka Przewodów Energetycznych S.A. Both companies are listed as successful framework participants for the same lot. Future requirements will be awarded through reopening of competition. This means the two approved suppliers may be invited to compete again for specific orders issued during the framework period. Key Contract Details Detail Information Contracting Entity Polskie Sieci Elektroenergetyczne S.A. (PSE) Successful Framework Supplier 1 NPA Skawina Sp. z o.o. Successful Framework Supplier 2 Fabryka Przewodów Energetycznych S.A. Country Poland Procurement Subject Framework agreement for the supply of phase conductors Sector Electricity transmission and overhead power line infrastructure Maximum Framework Value PLN 362,076,000 Framework Duration Five years Maximum Renewals None Procedure Type Open procedure Framework Model Framework agreement with reopening of competition Number of Tenders Received Four Tenders Submitted Electronically Four Tenders from SMEs Two Inadmissible Tenders Two Evaluation Criterion Price - 100% Winner Selection Date 30 April 2026 Contract Signing Date 7 July 2026 Contract Identifier - NPA Skawina 01625/2026 Contract Identifier - Fabryka Przewodów Energetycznych 01626/2026 CPV Code 31321100 - Overhead power lines Legal Framework Directive 2014/25/EU Government Procurement Agreement Covered TED Notice ID 480489-2026 TED Publication Date 13 July 2026 Project Scope The framework covers the supply of phase conductors for future electricity transmission requirements managed by PSE. Rather than committing the contracting entity to one fixed delivery under a single project, the agreement establishes the commercial and technical conditions under which individual orders can be awarded during the framework period. The detailed technical specifications are contained in the procurement documents and are not fully reproduced in the contract award notice. PSE allowed suppliers to propose equivalent technical solutions where they could demonstrate that those alternatives met requirements at least equal to the referenced standards and specifications. This approach can broaden technical participation while protecting the performance and reliability standards required for transmission infrastructure. The procurement also includes the possibility of using contractual options at the stage of individual call off orders. The precise use and value of those options will depend on future requirements. About the Contracting Authority Polskie Sieci Elektroenergetyczne S.A. Polskie Sieci Elektroenergetyczne S.A., commonly known as PSE, is Poland's electricity transmission system operator. Its role is to manage the country's high voltage transmission network, maintain the balance between electricity generation and demand and support the secure movement of power across Poland and through cross border connections. As the organisation responsible for nationally important transmission infrastructure, PSE requires a dependable supply of technically compliant equipment and materials for grid construction, maintenance, reinforcement and modernisation. In this procurement, PSE acts as the contracting entity and will manage future orders issued under the five year framework. About the Organisations Involved NPA Skawina Sp. z o.o. - Successful Framework Supplier NPA Skawina Sp. z o.o. is one of the two companies selected for the phase conductor framework. The company is based in Skawina in southern Poland and operates in the power conductor and electricity infrastructure supply market. NPA Skawina was ranked as a successful supplier for Lot 1 and signed framework contract number 01625/2026 on 7 July 2026. Its inclusion gives the company the opportunity to compete for individual supply orders issued by PSE during the framework period. However, selection for the framework does not necessarily guarantee a fixed share of the maximum value. The TED notice states that the status of subcontracting for the company's tender is not yet known. Fabryka Przewodów Energetycznych S.A. Successful Framework Supplier Fabryka Przewodów Energetycznych S.A. is the second successful supplier appointed to the framework. Based in Będzin, Poland, the company operates in the manufacture and supply of conductors used by the electricity sector. The company was ranked as a successful supplier for Lot 1 and signed framework contract number 01626/2026 on 7 July 2026. Like NPA Skawina, it will be eligible to participate in future competitions for specific PSE conductor requirements during the five year framework period. The TED notice classifies Fabryka Przewodów Energetycznych as a large economic operator. The status of subcontracting under its tender is not yet known. Krajowa Izba Odwoławcza Procurement Review Authority Krajowa Izba Odwoławcza, Poland's National Appeals Chamber, is identified as the review authority for the procurement. Its role is to hear challenges relating to public procurement procedures and provide legal review where eligible suppliers believe procurement rules have been breached. The organisation does not participate in the supply framework and has no commercial role in the contract. Ministerstwo Finansów Regulatory Information Organisation Poland's Ministry of Finance is identified as the organisation providing information concerning the general tax related regulatory framework applicable to the procurement. It is not a buyer, supplier or funding organisation for the conductor framework. Procurement Analysis PSE used an open procedure under Directive 2014/25/EU, the European Union's procurement framework for entities operating in sectors including electricity, water, transport and postal services. Four electronic tenders were received. Two came from micro, small or medium sized enterprises, indicating participation from companies of different scales. However, two of the four submissions were classified as inadmissible. The notice does not provide enough information to determine the specific reasons for their inadmissibility. The remaining successful tenders resulted in the appointment of NPA Skawina and Fabryka Przewodów Energetycznych to the framework. Price carried a weighting of 100%, making it the sole disclosed award criterion. Technical compliance remained a mandatory condition, but once those requirements were satisfied, price determined the competitive ranking. The framework will operate with reopening of competition. This is an important distinction because appointment to the framework does not automatically allocate all future demand to either company. When PSE requires conductors, it can conduct a further competition between the approved suppliers under the framework's established terms. Additional Procurement Facts Procurement Directive: Directive 2014/25/EU Nature of Contract: Supplies Procedure: Open procedure Accelerated Procedure: No Framework Agreement: Yes Reopening of Competition: Yes Dynamic Purchasing System: No Award Criterion: Price - 100% Maximum Framework Value: PLN 362,076,000 Framework Duration: Five years Maximum Renewals: None Total Tenders Received: Four Electronic Tenders: Four SME Tenders: Two Inadmissible Tenders: Two Tenders Rejected for Abnormally Low Price: None Government Procurement Agreement: Covered Market Consultation: Conducted before the procurement procedure Advance Payments: May be available for individual call off orders Market & Industry Perspective Europe's electricity networks are entering a period of sustained investment driven by renewable energy integration, electrification, cross border power flows and the need to replace ageing infrastructure. These changes increase demand not only for high profile assets such as substations and transmission towers but also for the conductors, insulators, fittings and other components that make electricity networks operational. Long term frameworks can help transmission operators manage supply chain risk by qualifying suppliers before individual project requirements arise. For conductor manufacturers, framework participation creates access to a multi year procurement pipeline. However, because competition will reopen for future orders, suppliers must continue competing on price and meeting delivery requirements after their initial appointment. The use of a 100% price criterion may place sustained pressure on manufacturing efficiency, raw material sourcing and logistics. At the same time, technical standards remain a critical entry requirement because transmission conductors must perform reliably over long operating periods. The framework may generate additional procurement activity in conductor accessories, transmission line fittings, installation services, testing, engineering support and grid maintenance requirements. Economic Significance With a maximum value of PLN 362.08 million, the framework represents a substantial long term procurement channel for Poland's electricity transmission supply chain. The stated amount is a maximum framework ceiling rather than a guaranteed payment to either supplier. Actual expenditure will depend on the value and volume of call off orders awarded during the agreement. The framework may provide PSE with greater purchasing flexibility while giving approved suppliers visibility over potential demand for the next five years. For the wider economy, reliable access to transmission components can support the timely delivery of grid investments needed for industrial development, renewable energy connections and electricity system security. The agreement may also support domestic manufacturing capacity by placing two Poland based conductor suppliers within a long term national transmission procurement programme. Future Procurement Opportunities The framework itself creates a continuing procurement pipeline because future conductor requirements will be awarded through competitions between the selected suppliers. These call off opportunities will primarily be available to the companies admitted to the framework rather than to the wider market. For businesses outside the framework, opportunities may emerge in related areas such as conductor components, raw materials, testing, logistics, engineering support and transmission line construction. Future grid projects may also generate demand for high capacity conductors, transmission line upgrades, substation equipment and technologies designed to increase the amount of electricity carried through existing infrastructure. The notice does not disclose a confirmed procurement timetable for additional conductor frameworks after the current five year term. Opportunities for Suppliers Manufacturers seeking future opportunities with electricity transmission operators should monitor procurement plans before formal tenders are published, as technical qualification and evidence requirements may require significant preparation. Suppliers of aluminium, conductor materials, fittings and specialised transmission components may find opportunities through the wider supply chains supporting the selected framework companies. Testing laboratories and certification providers may benefit from demand for technical verification and compliance documentation. Logistics companies capable of transporting long and heavy conductor reels may also find opportunities connected to future delivery orders. Engineering and installation contractors should monitor the transmission projects that generate demand under the framework, as conductor supply is often connected to broader line construction, reinforcement and modernisation programmes. What Businesses Should Watch Future call off competitions conducted between NPA Skawina and Fabryka Przewodów Energetycznych. New PSE transmission line construction and grid modernisation programmes. Demand for conductors supporting renewable energy connections. Transmission upgrades intended to increase network capacity and resilience. Future procurement of insulators, fittings, towers and other overhead line components. Raw material price movements that may affect conductor manufacturing costs. Opportunities involving testing, logistics, installation and technical support. Future PSE framework agreements as the current five year procurement cycle approaches completion. PolandTenders.com Procurement Intelligence The strategic value of this award lies not only in its PLN 362 million ceiling but in the procurement structure chosen by PSE. Instead of relying on one supplier for five years, the transmission operator has created a qualified two company supply pool and retained the ability to reopen competition whenever specific requirements arise. This approach provides a balance between supply continuity and price discipline. The framework reduces the time required to source critical conductors, while future mini competitions can allow PSE to compare commercial offers as market conditions change. The model may be particularly useful in a sector exposed to fluctuations in aluminium prices, energy costs, manufacturing capacity and infrastructure demand. The procurement also demonstrates that winning admission to a framework is only the first stage of the commercial process. NPA Skawina and Fabryka Przewodów Energetycznych have secured access to future opportunities, but they may still need to compete for individual orders. For suppliers outside the framework, the most relevant opportunities may sit around the main contract. Transmission investment creates demand across a broader ecosystem involving raw materials, fittings, testing, logistics, construction and maintenance. As Poland expands and modernises its electricity network, long term component frameworks may become increasingly important tools for reducing procurement delays and protecting infrastructure delivery schedules. Supplier Takeaways Monitor PSE's transmission investment pipeline to identify future component demand. Prepare technical evidence and certification before major utility tenders are published. Recognise that framework appointment may provide market access without guaranteeing order volume. Build cost efficient manufacturing and sourcing strategies where price is the primary award criterion. Explore supply chain opportunities with successful framework participants. Track demand for conductor fittings, testing, logistics and installation services. Follow future grid projects connected to renewable energy and transmission capacity expansion. Key Takeaways PSE has established a five year framework for the supply of phase conductors. The framework has a maximum value of PLN 362,076,000. NPA Skawina Sp. z o.o. and Fabryka Przewodów Energetycznych S.A. were selected as successful suppliers. Both framework contracts were signed on 7 July 2026. Four electronic tenders were received, including two from SMEs. Two submissions were classified as inadmissible. Price accounted for 100% of the award evaluation. Future orders will be awarded through reopening of competition between the selected suppliers. The framework will operate for five years or until its maximum value is reached, whichever occurs first. The agreement supports long term access to critical components for Poland's electricity transmission network. Conclusion Poland's PLN 362 million conductor framework is not tied to one transmission line or a single construction site. Its importance lies in creating a long term supply route for components that are essential to the operation and expansion of the national electricity network. By selecting two domestic suppliers and reopening competition for future requirements, PSE has combined procurement efficiency with continuing commercial pressure. The agreement also shows how infrastructure strategy extends beyond major construction contracts. Grid reliability depends on securing the materials required to build, reinforce and maintain transmission assets over many years. For NPA Skawina and Fabryka Przewodów Energetycznych, framework appointment creates access to a substantial procurement pipeline. For the wider market, future opportunities may emerge across manufacturing inputs, testing, logistics, engineering and transmission line delivery. Frequently Asked Questions What is the value of Poland's phase conductor framework? The maximum value of the framework agreement is PLN 362,076,000. Who awarded the framework agreement? Polskie Sieci Elektroenergetyczne S.A. (PSE), Poland's electricity transmission system operator, conducted the procurement. Which companies were selected as successful suppliers? NPA Skawina Sp. z o.o. and Fabryka Przewodów Energetycznych S.A. were selected as successful framework suppliers. What are phase conductors? Phase conductors are the electrically active cables suspended from transmission towers that carry electricity through an overhead power network. How long will the framework operate? The framework is intended to operate for five years from signing or until its maximum contractual value is reached, whichever occurs first. Does each winning company receive PLN 362 million? No. PLN 362.08 million is the maximum value of the overall framework. It should not be interpreted as a guaranteed payment to each supplier. How will future orders be awarded? PSE will reopen competition between the selected framework suppliers when awarding individual requirements under the agreement. How many tenders were received? Four electronic tenders were received. Two were submitted by micro, small or medium sized enterprises, while two submissions were classified as inadmissible. What was the award criterion? Price accounted for 100% of the disclosed award evaluation. When were the contracts signed? The contracts with both successful framework suppliers were concluded on 7 July 2026. What future opportunities could emerge? Potential opportunities may arise in conductor materials, transmission fittings, testing, logistics, engineering, line installation, grid maintenance and future electricity network expansion projects. Source Source: TED (Tenders Electronic Daily) - Contract Award Notice 480489-2026, published on 13 July 2026. :contentReference[oaicite:0]{index=0}
View Details